Design, synthesis and biological evaluation of novel desloratadine derivatives with anti-inflammatory and H1 antagonize activities

Bioorg Med Chem Lett. 2019 Dec 15;29(24):126712. doi: 10.1016/j.bmcl.2019.126712. Epub 2019 Oct 15.

Abstract

To improve the anti-inflammatory activity of desloratadine, we designed and synthesized a series of novel desloratadine derivatives. All compounds were evaluated for their anti-inflammatory and H1 antagonistic activities. Among them, compound 2c showed the strongest H1 antagonistic and anti-inflammatory activity. It also exhibited promising pharmacokinetic profiles and low toxicity. All these results suggest that compound 2c as a novel anti-allergic agent is worthy of further investigation.

Keywords: Anti-allergic; Anti-inflammatory; Desloratadine; H(1) antagonize.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Histamine H1 Antagonists / pharmacology
  • Histamine H1 Antagonists / therapeutic use*
  • Humans
  • Loratadine / analogs & derivatives*
  • Loratadine / chemical synthesis
  • Loratadine / chemistry
  • Structure-Activity Relationship

Substances

  • Anti-Inflammatory Agents
  • Histamine H1 Antagonists
  • Loratadine
  • desloratadine